Novel Drug Delivery Technologies Innovative Strategies for Drug Re-positioning /

The application of drug delivery is a valuable, cost-effective lifecycle management resource. By endowing drugs with new and innovative therapeutic benefits, drug delivery systems extend products' profitable lifecycle, giving pharmaceutical companies competitive and financial advantages, and pr...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Misra, Ambikanandan (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Shahiwala, Aliasgar (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Singapore : Springer Singapore : Imprint: Springer, 2019.
Έκδοση:1st ed. 2019.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04718nam a2200529 4500
001 978-981-13-3642-3
003 DE-He213
005 20200212173839.0
007 cr nn 008mamaa
008 200212s2019 si | s |||| 0|eng d
020 |a 9789811336423  |9 978-981-13-3642-3 
024 7 |a 10.1007/978-981-13-3642-3  |2 doi 
040 |d GrThAP 
050 4 |a RM1-950 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
072 7 |a MKG  |2 thema 
082 0 4 |a 615  |2 23 
245 1 0 |a Novel Drug Delivery Technologies   |h [electronic resource] :  |b Innovative Strategies for Drug Re-positioning /  |c edited by Ambikanandan Misra, Aliasgar Shahiwala. 
250 |a 1st ed. 2019. 
264 1 |a Singapore :  |b Springer Singapore :  |b Imprint: Springer,  |c 2019. 
300 |a XXIV, 431 p. 62 illus., 40 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Chapter 1. Poorly water soluble drugs and formulation strategies to improve oral bioavailability -- Chapter 2. Buccal and intraoral drug delivery: Potential alternative to conventional therapy -- Chapter 3. Gastro-retentive drug delivery Systems: Current strategies and challenges -- Chapter 4. Peyer's patch: Targeted drug delivery for therapeutics benefits -- Chapter 5. Colonic drug delivery systems as Multi-unit potential: Therapeutic strategies and opportunities -- Chapter 6. Controlled and prolonged drug delivery systems: Therapeutics needs and formulation strategies -- Chapter 7. Transdermal drug administration: Emerging techniques and improved patient compliance -- Chapter 8. Inhalation drug therapy: Emerging trends in Nasal and pulmonary drug delivery -- Chapter 9. Ophthalmic and otic drug administration: Novel approaches and challenges -- Chapter 10. Targeted drug delivery to brain: Challenges and formulation approaches -- Chapter 11. Opportunities and challenges in targeted carrier based drug delivery: Increased efficacy & reduced toxicity. 
520 |a The application of drug delivery is a valuable, cost-effective lifecycle management resource. By endowing drugs with new and innovative therapeutic benefits, drug delivery systems extend products' profitable lifecycle, giving pharmaceutical companies competitive and financial advantages, and providing patients with improved medications. Formulation development is now being used to create new dosage forms for existing products, which not only reduces the time and expense involved in new drug development, but also helps with regard to patent protection and bypassing existing patents. Today's culture demands convenience, a major factor determining adherence to drug therapy. Over the past few years, patient convenience-oriented research in the field of drug delivery has yielded a range of innovative drug-delivery options. As a result, various drug-delivery systems, including medicated chewing gums, oral dispersible tablets, medicated lozenges and lollipops, have now hit the market and are very popular. These dosage forms offer a highly convenient way to dose medications, not only for special population groups with swallowing difficulties, such as children and the elderly, but for the general populace as well. This book provides valuable insights into a number of formulation design approaches that are currently being used, or could be used, to provide new benefits from existing drug molecules. 
650 0 |a Pharmacology. 
650 0 |a Pharmacy. 
650 0 |a Medicinal chemistry. 
650 0 |a Nanochemistry. 
650 1 4 |a Pharmacology/Toxicology.  |0 http://scigraph.springernature.com/things/product-market-codes/B21007 
650 2 4 |a Drug Safety and Pharmacovigilance.  |0 http://scigraph.springernature.com/things/product-market-codes/H69010 
650 2 4 |a Medicinal Chemistry.  |0 http://scigraph.springernature.com/things/product-market-codes/C28000 
650 2 4 |a Pharmacy.  |0 http://scigraph.springernature.com/things/product-market-codes/F00008 
650 2 4 |a Nanochemistry.  |0 http://scigraph.springernature.com/things/product-market-codes/C33000 
700 1 |a Misra, Ambikanandan.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Shahiwala, Aliasgar.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9789811336416 
776 0 8 |i Printed edition:  |z 9789811336430 
776 0 8 |i Printed edition:  |z 9789811512735 
856 4 0 |u https://doi.org/10.1007/978-981-13-3642-3  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)